Rapha Capital Management

Rapha Capital Management, LLC, founded in mid-2018, focuses on identifying and growing revolutionary ideas in medicine, healthcare, and technology. The firm is led by Dr. Kevin Slawin, a pioneer in robotic surgery and immunotherapy, who has a proven track record of successful ventures, including Bellicum Pharmaceuticals. With a portfolio of 13 managed entities, Rapha Capital aims to invest in early-stage biopharmaceutical companies that have the potential to significantly improve patient outcomes and create substantial value in the healthcare sector.